Read our most recent press releases and new articles
When we’re not making news with breakthroughs in clinical research, we’re in the news. See our news and press release archive below.
- Pennsylvania Small Business Development Centers Success Story: “Clarion Research Group”, May 31, 2011
Dr. James Rutkowski has maintained a private dental practice in Clarion since 1983. Using his dental lab, Dr. Rutkowski designed a device called the “VeinStay” that holds the vein in place during venipuncture, and he has successfully used it in his practice for the last five years. Read more.
- Bucknell University Success Story: VeinStay: “Clarion Research Group Taps into Prototyping Resources”, June 27, 2008
Dr. James Rutkowski is a dentist and pharmacology researcher who recognized the need for improving the way blood draws are conducted. Avoiding multiple “sticks”; thereby saving time and reducing patient discomfort, his new “ VeinStay” product provides a more secure method of piercing a patient’s vein by pressing on the patient’s skin, making the veins more apparent and holding them in place for an easier and lower risk procedure. When the concept showed great promise in his own “in-house” use, he turned to the SBDC for assistance in commercializing the product. Read more.
- Ben Franklin Technology Partners Press Release: “Clarion Research Group Technology Induces Bone Growth”, March 17, 2011
Clarion Research Group (CRG) owns the license to a patent-pending platform technology that induces bone formation, which is very significant to the dental and orthopedic markets. Read more.
- Keystone Edge News: Growing Companies: Clarion Research Group
In his dental implant practice, Dr. James Rutkowski has observed that the use of a new product called OsteoXcell-1000 accelerated bone growth by 60 percent. The growth is significant in the oral surgery arena, in which current bone graft products often are cost-prohibitive or limit alternatives available to the patient. Slow or impaired healing can cause health complications and discomfort. Read more.